Peptides and the gut barrier
A lot of gut-peptide interest centers on the intestinal barrier — the lining that controls what passes from the gut into the body. When that barrier is disrupted (sometimes called "leaky gut"), it's linked to inflammatory and autoimmune conditions.[2] Several peptides are studied for protecting or restoring this barrier and calming gut inflammation.
Which peptides are studied for the gut
| Peptide | Gut angle | Status |
|---|---|---|
| Teduglutide | Regrows intestinal lining in short bowel syndrome | FDA-approved |
| Linaclotide / plecanatide | IBS-C and chronic constipation | FDA-approved |
| Larazotide | Tightens the gut barrier (studied in celiac disease) | Investigational[1] |
| BPC-157 | Gut/tissue healing — its original research focus | Research chemical (animal data) |
| KPV | Anti-inflammatory in the gut | Research chemical |
| VIP | Gut signaling & anti-inflammation | Endogenous / investigational |
The spread is instructive: the approved gut peptides treat specific diagnosed conditions, while the popular "gut healing" ones (BPC-157, KPV) rest on animal data.
BPC-157 and the gut
BPC-157 is the peptide most marketed for gut health, and notably its original research was about the gastrointestinal tract — it derives from a protective protein found in gastric juice, and rodent studies show protection and healing of stomach and intestinal lesions. But this remains animal evidence: there are no completed human trials, and it's an unapproved research chemical. Promising origin story, unproven in people.
The honest bottom line
If you have a diagnosed gut condition, the relevant peptides may be approved medicines (teduglutide, linaclotide, plecanatide) prescribed by a doctor — real, proven options. The "gut healing" research peptides sold online are a different tier: biologically interesting, unproven in humans, and unregulated. See are peptides safe? and how peptide research is graded.
Frequently asked questions
What peptides are good for gut health?
It depends on the goal. FDA-approved gut peptides include teduglutide (short bowel syndrome) and linaclotide/plecanatide (IBS-C and constipation). Larazotide is investigational for the gut barrier. BPC-157 and KPV are popular for 'gut healing' but rest on animal data and are unapproved.
Does BPC-157 heal the gut?
BPC-157's original research focused on the gastrointestinal tract, and rodent studies show it protects and heals stomach and intestinal lesions. However, there are no completed human trials, so its effect on the human gut is unproven, and it is an unapproved research chemical.
Are there peptides for leaky gut?
Larazotide is the peptide most associated with the intestinal barrier ('leaky gut'), studied to tighten the gut lining in conditions like celiac disease, but it remains investigational and not approved. 'Leaky gut' itself is a still-developing area of research.
Which gut peptides are FDA-approved?
Teduglutide (Gattex) for short bowel syndrome, and linaclotide (Linzess) and plecanatide (Trulance) for IBS with constipation and chronic constipation, are FDA-approved gut peptides. BPC-157, KPV, and larazotide are not approved.
Further reading
Selected peer-reviewed sources on this topic, labelled by type. A citation is a reference, not an endorsement.
- Tajik N, Frech M, Schulz O, et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun. 2020. Peer-reviewed study
- Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009. Peer-reviewed study